# Presurance Holdings, Inc.: overview PRHI · Nasdaq · CIK 1502292 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/prhi.md) · [Financials](/companies/prhi/financials.md) · [Filings](/companies/prhi/filings.md) · [Insiders](/companies/prhi/insiders.md) Latest reported revenue: [$9.1m](/filings/0001193125-26-346778.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-346778). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [16.0](/filings/0001193125-25-277589.md) | [14.7 d](/filings/0001193125-26-129019.md) | [15.9](/filings/0001193125-26-221549.md) | [16.1](/filings/0001193125-26-346778.md) | [6.7](/filings/0001193125-25-277589.md) | [4.6 d](/filings/0001193125-26-129019.md) | [11.5](/filings/0001193125-26-221549.md) | [9.1](/filings/0001193125-26-346778.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(45.8%)](/filings/0001193125-25-277589.md) | [(178.6%) d](/filings/0001193125-26-129019.md) | [(27.9%)](/filings/0001193125-26-221549.md) | [(12.4%)](/filings/0001193125-26-346778.md) | [(43.6%)](/filings/0001193125-25-277589.md) | [(322.7%) d](/filings/0001193125-26-129019.md) | [(9.2%)](/filings/0001193125-26-221549.md) | [22.7%](/filings/0001193125-26-346778.md) | | Net margin | % | [329.6%](/filings/0000950170-24-126271.md) | [(166.8%) d](/filings/0001193125-26-129019.md) | [3.3%](/filings/0001193125-26-221549.md) | [12.7%](/filings/0001193125-26-346778.md) | [(59.4%)](/filings/0001193125-25-277589.md) | [(369.2%) d](/filings/0001193125-26-129019.md) | [22.7%](/filings/0001193125-26-221549.md) | [27.7%](/filings/0001193125-26-346778.md) | | Diluted EPS | $ per share | [4.32](/filings/0001193125-25-277589.md) | not reported | [0.04](/filings/0001193125-26-221549.md) | [1.17](/filings/0001193125-26-346778.md) | [(0.32)](/filings/0001193125-25-277589.md) | not reported | [0.15](/filings/0001193125-26-221549.md) | [0.68](/filings/0001193125-26-346778.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [116](/filings/0000950170-23-009881.md) | [105](/filings/0000950170-24-039426.md) | [90.5](/filings/0000950170-25-046719.md) | [67.3](/filings/0001193125-26-129019.md) | [43.3](/filings/0001193125-26-129019.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(11.5%)](/filings/0000950170-23-009881.md) | [(27.0%)](/filings/0000950170-24-039426.md) | [(33.7%)](/filings/0000950170-25-046719.md) | [(55.4%)](/filings/0001193125-26-129019.md) | [(59.8%)](/filings/0001193125-26-129019.md) | | Net margin | % | [(0.9%)](/filings/0000950170-23-009881.md) | [(10.2%)](/filings/0000950170-24-039426.md) | [(28.6%)](/filings/0000950170-24-039426.md) | [36.2%](/filings/0001193125-26-129019.md) | [(42.6%)](/filings/0001193125-26-129019.md) | | Diluted EPS | $ per share | [(0.11)](/filings/0000950170-23-009881.md) | [(1.00)](/filings/0000950170-24-039426.md) | [(2.12)](/filings/0000950170-25-046719.md) | [1.93](/filings/0001193125-26-129019.md) | [(1.51)](/filings/0001193125-26-129019.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/prhi/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [IAT REINSURANCE CO LTD.](/funds/1633625.md) | 2026-06-30 | $175.4k | 35,714 | | New +35,714 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $49.3k | 10,040 | | New +10,040 | | [Nemes Rush Group LLC](/funds/1982273.md) | 2026-06-30 | $18.4k | 3,741 | | New +3,741 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $12.1k | 2,455 | | New +2,455 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $5.1k | 1,041 | | New +1,041 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $3.4k | 683 | | New +683 | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $2.8k | 571 | | New +571 | | [CoreCap Advisors, LLC](/funds/1902501.md) | 2026-06-30 | $2.8k | 562 | | New +562 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $368 | 75 | | New +75 | ## Recent filings [All 478 filings](/companies/prhi/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-14 | 12:47 ET | [8-K](/filings/0001193125-26-350625.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-350625 | | 2026-08-12 | 20:00 ET | [10-Q](/filings/0001193125-26-346778.md) | Quarterly report, period 2026-06-30 | 0001193125-26-346778 | | 2026-06-04 | 18:57 ET | [8-K](/filings/0001193125-26-257186.md) | 5.07 Shareholder vote results | 0001193125-26-257186 | | 2026-05-28 | 21:10 ET | [8-K](/filings/0001193125-26-245505.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-245505 | | 2026-05-14 | 19:24 ET | [8-K](/filings/0001193125-26-223815.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-223815 | | 2026-05-13 | 20:00 ET | [10-Q](/filings/0001193125-26-221549.md) | Quarterly report, period 2026-03-31 | 0001193125-26-221549 | | 2026-04-24 | 20:53 ET | [DEF 14A](/filings/0001140361-26-016748.md) | Proxy statement, period 2026-06-03 | 0001140361-26-016748 | | 2026-03-30 | 21:31 ET | [8-K](/filings/0001193125-26-131827.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-131827 | | 2026-03-27 | 20:10 ET | [10-K](/filings/0001193125-26-129019.md) | Annual report, period 2025-12-31 | 0001193125-26-129019 | | 2026-03-06 | 21:03 ET | [8-K](/filings/0001193125-26-096466.md) | 3.01 Delisting notice | 0001193125-26-096466 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-129019.md), filed Mar 27, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/69c612e3-2c20-48af-a21a-613f02f53ab2) ## About the filer - CIK: 1502292 - Tickers: PRHI, PRHIZ - Exchange: Nasdaq - SIC code: 6331 Fire, Marine & Casualty Insurance - State of incorporation: MI - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.